Stock listing

Shanghai:600079 Humanwell Healthcare (Group) Co.,Ltd. (ST人福) 股价

Follow Humanwell Healthcare (Group) Co.,Ltd. into a list and get an email when it puts out news.

Share price · SSE:600079

¥19.18 CNY +0.10 (+0.5%)

Close on Nov 3, 2026

Past year -7.5% · daily closes, Nov 3, 2025 – Nov 3, 2026, adjusted for splits
Day range
¥19.05 – ¥19.34 CNYNov 3, 2026
Volume
7.84M sharesNov 3, 2026
Market cap
¥31.31B CNYAt the close on Nov 3, 2026 · price × 1.63B shares outstanding
52-week range
¥16.03 – ¥20.95 CNYLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
Traded on an average day
¥194.8M CNYMedian day 8.44M shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Humanwell Healthcare (Group) Co.,Ltd. logo

Daily closes

Last 3 months, Aug 3, 2026 – Nov 3, 2026 · SSE:600079 · CNY, adjusted for splits

DayCloseChange%OpenHighLowVolume
¥19.18+0.10+0.5%¥19.08¥19.34¥19.057,837,720
¥19.08-0.05-0.3%¥19.15¥19.22¥18.879,017,700
¥19.13-0.32-1.6%¥19.30¥19.58¥19.0413,279,600
¥19.45-0.11-0.6%¥19.57¥19.74¥19.3810,106,100
¥19.56+0.06+0.3%¥19.54¥19.70¥19.437,151,800
¥19.50-0.20-1.0%¥19.71¥19.88¥19.4010,436,897
¥19.70+0.42+2.2%¥19.27¥19.78¥19.1911,599,800
¥19.28+0.22+1.2%¥18.98¥19.30¥18.7014,055,700
¥19.06-0.43-2.2%¥19.45¥19.57¥19.0013,226,300
¥19.49-0.06-0.3%¥19.62¥19.92¥19.478,313,900
¥19.55+0.25+1.3%¥19.30¥19.75¥19.1513,713,400
¥19.30+0.41+2.2%¥18.88¥19.64¥18.8322,872,359
¥18.89-1.10-5.5%¥20.01¥20.69¥18.6254,445,444
¥19.99+0.07+0.4%¥19.80¥20.15¥19.6721,093,315
¥19.92+0.23+1.2%¥19.65¥19.95¥19.5813,152,900
¥19.69+0.04+0.2%¥19.60¥19.78¥19.3812,307,700
¥19.65+0.42+2.2%¥19.23¥19.88¥19.2021,066,900
¥19.23+0.05+0.3%¥19.19¥19.32¥19.0110,808,200
¥19.18+0.01+0.1%¥19.19¥19.32¥19.0610,818,656
¥19.17+0.34+1.8%¥18.92¥19.19¥18.9012,094,020
¥18.83+0.02+0.1%¥18.80¥19.00¥18.756,073,900
¥18.81-0.01-0.1%¥18.86¥18.97¥18.607,510,700
¥18.82-0.01-0.1%¥18.88¥19.18¥18.808,907,508
¥18.83+0.10+0.5%¥18.69¥18.88¥18.675,575,334
¥18.73-0.05-0.3%¥18.73¥18.80¥18.634,786,100
¥18.78+0.32+1.7%¥18.58¥18.82¥18.497,817,702
¥18.46+0.04+0.2%¥18.42¥18.56¥18.404,163,702
¥18.42+0.03+0.2%¥18.32¥18.46¥18.322,853,853
¥18.39-0.11-0.6%¥18.45¥18.58¥18.326,058,604
¥18.50-0.04-0.2%¥18.53¥18.68¥18.406,292,500
¥18.54+0.21+1.1%¥18.32¥18.55¥18.305,626,500
¥18.33-0.25-1.3%¥18.55¥18.56¥18.2511,123,300
¥18.58-0.03-0.2%¥18.54¥18.65¥18.505,647,400
¥18.61-0.19-1.0%¥18.80¥18.80¥18.588,030,300
¥18.80-0.06-0.3%¥18.87¥18.91¥18.755,445,100
¥18.86+0.13+0.7%¥18.79¥18.99¥18.726,217,300
¥18.73-0.16-0.8%¥18.89¥18.90¥18.719,486,702
¥18.890.000.0%¥18.88¥18.95¥18.846,274,900
¥18.89+0.03+0.2%¥18.81¥18.97¥18.788,443,202
¥18.86+0.25+1.3%¥18.59¥18.92¥18.5611,085,447
¥18.61-0.05-0.3%¥18.67¥18.71¥18.568,354,800
¥18.66+0.21+1.1%¥18.46¥18.69¥18.4610,401,631
¥18.45-0.01-0.1%¥18.40¥18.55¥18.329,578,728
¥18.46+0.44+2.4%¥18.33¥18.76¥18.2521,734,838
¥18.02+0.17+1.0%¥17.85¥18.02¥17.815,420,300
¥17.85-0.04-0.2%¥17.87¥17.94¥17.755,591,600
¥17.89+0.03+0.2%¥17.82¥17.90¥17.638,281,319
¥17.86-0.19-1.1%¥18.04¥18.20¥17.8311,124,429
¥18.05+0.14+0.8%¥17.92¥18.27¥17.9012,330,645
¥17.910.000.0%¥17.90¥17.97¥17.825,455,093
¥17.91-0.08-0.4%¥17.91¥18.01¥17.798,135,500
¥17.99-0.08-0.4%¥18.08¥18.16¥17.967,496,900
¥18.07+0.01+0.1%¥18.10¥18.18¥18.016,861,200
¥18.06+0.10+0.6%¥17.96¥18.07¥17.875,914,900
¥17.96-0.16-0.9%¥18.13¥18.31¥17.8613,961,400
¥18.12+0.17+0.9%¥17.94¥18.35¥17.9114,901,832
¥17.95+0.14+0.8%¥17.81¥17.99¥17.758,234,801
¥17.81+0.13+0.7%¥17.61¥17.84¥17.588,459,479
¥17.68+0.13+0.7%¥17.55¥17.71¥17.459,024,379
¥17.55-0.14-0.8%¥17.76¥17.80¥17.518,264,600
¥17.69-0.22-1.2%¥17.60¥17.73¥17.517,542,400
Ticker
Shanghai:600079
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Shanghai
Currency
CNY

What changed lately

Latest news

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining Marketing Authorization for Fentanyl Citrate Injection from the German Federal Institute for Drugs and Medical Devices (BfArM)

Nov 3, 2026

Closed ¥19.18 (+0.5%) on Nov 3, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Approval of Registration for Super Short-term Commercial Paper

Nov 3, 2026

Closed ¥19.18 (+0.5%) on Nov 3, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Report for Q3 2026

Oct 30, 2026

Closed ¥19.13 (-1.6%) on Oct 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Resolutions of the 13th Meeting of the 11th Board of Directors

Oct 30, 2026

Closed ¥19.13 (-1.6%) on Oct 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Conducting Foreign Exchange Derivatives Trading Business

Oct 30, 2026

Closed ¥19.13 (-1.6%) on Oct 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the U.S. FDA Approval Number for Lubiprostone Soft Capsules

Oct 20, 2026

Closed ¥19.55 (+1.3%) on Oct 20, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the Marketing Authorization for Sugammadex Sodium Injection from the UK Medicines and Healthcare Products Regulatory Agency (MHRA)

Oct 14, 2026

Closed ¥19.92 (+1.2%) on Oct 14, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on Obtaining the US FDA Approval Number for Diltiazem Hydrochloride Tablets

Oct 9, 2026

Closed ¥19.23 (+0.3%) on Oct 9, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Indicative Announcement on Disclosure of Proposal for 2026 Private Placement of A-Shares (Second Revised Draft)

Sep 30, 2026

Closed ¥19.17 (+1.8%) on Sep 30, 2026

(600079)"Humanwell Healthcare (Group) Co., Ltd."Announcement on the Dilution of Immediate Returns, Measures to Mitigate Such Dilution and the Undertakings by Relevant Parties in Relation to the Private Placement of A-Shares (Second Revised Draft)

Sep 30, 2026

Closed ¥19.17 (+1.8%) on Sep 30, 2026

All Humanwell Healthcare (Group) Co.,Ltd. news

Financings

  • Super short-term commercial paper

    Nov 3, 2026

    Update: 上海浦东发展银行股份有限公司

    Dealers: 上海浦东发展银行股份有限公司 (co-lead)

    Update Nov 3, 2026

  • Private placement of a-shares

    Sep 30, 2026 · US$499.45M

    Terms changed: CNY 3.35B

    Insiders: Shares are to be subscribed by the controlling shareholder under a conditional share subscription agreement; treated as a related party transaction

    Use of proceeds: Innovative drug R&D, a health and complex formulations manufacturing base, digital and intelligent upgrades, and working capital

    Update Sep 24, 2026 · Terms changed Sep 30, 2026 · Update Sep 30, 2026

Read by 6ix AI from the company's releases

Humanwell Healthcare (Group) Co.,Ltd. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
66 in the last 12 months · 85 in all · newest Nov 3, 2026 · oldest 2015

Log in to ask 6ix AI your own questions about Humanwell Healthcare (Group) Co.,Ltd.